humulin n kwikpen 100 i.e./ml suspenzija za injiciranje
eli lilly farmacevtska druŽba, d.o.o. - insulin, humani - suspenzija za injiciranje - insulin, humani 100 i.e. / 1 ml - humani insulin
humulin m3 100 i.e./ml suspenzija za injiciranje v vložku
eli lilly farmacevtska druŽba, d.o.o. - insulin, humani - suspenzija za injiciranje - insulin, humani 100 i.e. / 1 ml - humani insulin
humulin n 100 i.e./ml suspenzija za injiciranje v vložku
eli lilly farmacevtska druŽba, d.o.o. - insulin, humani - suspenzija za injiciranje - insulin, humani 100 i.e. / 1 ml - humani insulin
ruconest
pharming group n.v. - rekombinantne človeške c1-inhibitor - angioedem, dedno - drugs used in hereditary angioedema, other hematological agents - zdravilo ruconest je indicirano za zdravljenje akutnih napadov angioedem pri odraslih z dednim angioedemom (hae) zaradi pomanjkanja inhibitorja c1-esteraze.
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedem, dedno - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
etindros 0,03 mg/3 mg filmsko obložene tablete
laboratorios leon farma s.a. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,03 mg / 1 tableta; etinilestradiol 0,03 mg / 1 tableta - drospirenon in etinilestradiol
etindros 0,02 mg/3 mg filmsko obložene tablete
laboratorios leon farma s.a. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,02 mg / 1 tableta; etinilestradiol 0,02 mg / 1 tableta - drospirenon in etinilestradiol
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, sistemski - imunosupresivi - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, sistemski - imunosupresivi - benlysta je indicirano kot dodatek terapije pri bolnikih, starih 5 let in več, z aktivno, autoantibody pozitivno sistemski eritematozni lupus (sle), z visoko stopnjo aktivnosti bolezni (e. pozitivni anti dsdna in nizko dopolnitev) kljub standardne terapije. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, dedno - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.